SARS-CoV-2 infection and acute ischemic stroke in Lombardy, Italy.


Journal

Journal of neurology
ISSN: 1432-1459
Titre abrégé: J Neurol
Pays: Germany
ID NLM: 0423161

Informations de publication

Date de publication:
Jan 2022
Historique:
received: 27 01 2021
accepted: 18 05 2021
revised: 05 05 2021
pubmed: 26 5 2021
medline: 11 1 2022
entrez: 25 5 2021
Statut: ppublish

Résumé

To characterize patients with acute ischemic stroke related to SARS-CoV-2 infection and assess the classification performance of clinical and laboratory parameters in predicting in-hospital outcome of these patients. In the setting of the STROKOVID study including patients with acute ischemic stroke consecutively admitted to the ten hub hospitals in Lombardy, Italy, between March 8 and April 30, 2020, we compared clinical features of patients with confirmed infection and non-infected patients by logistic regression models and survival analysis. Then, we trained and tested a random forest (RF) binary classifier for the prediction of in-hospital death among patients with COVID-19. Among 1013 patients, 160 (15.8%) had SARS-CoV-2 infection. Male sex (OR 1.53; 95% CI 1.06-2.27) and atrial fibrillation (OR 1.60; 95% CI 1.05-2.43) were independently associated with COVID-19 status. Patients with COVID-19 had increased stroke severity at admission [median NIHSS score, 9 (25th to75th percentile, 13) vs 6 (25th to75th percentile, 9)] and increased risk of in-hospital death (38.1% deaths vs 7.2%; HR 3.30; 95% CI 2.17-5.02). The RF model based on six clinical and laboratory parameters exhibited high cross-validated classification accuracy (0.86) and precision (0.87), good recall (0.72) and F1-score (0.79) in predicting in-hospital death. Ischemic strokes in COVID-19 patients have distinctive risk factor profile and etiology, increased clinical severity and higher in-hospital mortality rate compared to non-COVID-19 patients. A simple model based on clinical and routine laboratory parameters may be useful in identifying ischemic stroke patients with SARS-CoV-2 infection who are unlikely to survive the acute phase.

Identifiants

pubmed: 34031747
doi: 10.1007/s00415-021-10620-8
pii: 10.1007/s00415-021-10620-8
pmc: PMC8142879
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-11

Subventions

Organisme : Regione Lombardia
ID : STROKOVID

Informations de copyright

© 2021. The Author(s).

Références

Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS et al (2020) Extrapulmonary manifestations of COVID-19. Nat Med 26:1017–1032
doi: 10.1038/s41591-020-0968-3
Harapan BN, Yoo HJ (2021) Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19). J Neurol. https://doi.org/10.1007/s00415-021-10406-y
doi: 10.1007/s00415-021-10406-y pubmed: 33486564 pmcid: 7826147
Pezzini A, Padovani A (2020) Lifting the mask on neurological manifestations of COVID-19. Nat Rev Neurol. https://doi.org/10.1038/s41582-020-0398-3
doi: 10.1038/s41582-020-0398-3 pubmed: 32839585 pmcid: 7444680
Ntaios G, Michel P, Georgiopoulos G, Guo Y, Li W, Xiong J et al (2020) Characteristics and outcomes in patients with COVID-19 and acute ischemic stroke: the Global COVID-19 Stroke Registry. Stroke. https://doi.org/10.1161/STROKEAHA.120.031208
doi: 10.1161/STROKEAHA.120.031208 pubmed: 32787707 pmcid: 7359900
Katz JM, Libman RB, Wang JJ et al (2020) Cerebrovascular complications of COVID-19. Stroke 51:e227–e231
doi: 10.1161/STROKEAHA.120.031265
Padmanabhan N, Natarajan I, Gunston R, Raseta M, Roffe C (2021) Impact of COVID-19 on stroke admissions, treatments, and outcomes at a comprehensive stroke centre in the United Kingdom. Neurol Sci 42:15–20
doi: 10.1007/s10072-020-04775-x
Perry RJ, Smith CJ, Roffe C, Simister R, Narayanamoorthi S, Marigold R et al (2021) Characteristics and outcomes of COVID-19 associated stroke: a UK multicenter case–control study. J Neurol Neurosurg Psychiatry 92:242–248
doi: 10.1136/jnnp-2020-324927
Yaghi S, Ishida K, Torres J, Mac Grory B, Raz E, Humbert K et al (2020) SARS-CoV-2 and stroke in a New York healthcare system. Stroke 51:2002–2011
doi: 10.1161/STROKEAHA.120.030335
Kihira S, Schefflein J, Mahmoudi K, Rigney B, Delman B, Mocco J et al (2021) Association of coronavirus disease (COVID-19) with large vessel occlusion strokes: a case-control study. AJR Am J Roentgenol 216:150–156
doi: 10.2214/AJR.20.23847
John S, Hussain SI, Piechowski-Jozwiak B, Dibu J, Kesav P, Bayrlee A et al (2020) Clinical characteristics and admission patterns of stroke patients during the COVID 19 pandemic: a single center retrospective, observational study from the Abu Dhabi, United Arab Emirates. Clin Neurol Neurosurg 199:106227
doi: 10.1016/j.clineuro.2020.106227
Vandenbroucke JP, von Elm E, Altman DG et al (2007) Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration. PLoS Med 4:e297
doi: 10.1371/journal.pmed.0040297
Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K et al (2019) Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 50:e344–e418
doi: 10.1161/STR.0000000000000211
Adams HP, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL et al (1993) Classification of subtype of acute ischemic stroke Definitions for use in a multicenter clinical trial TOAST Trial of Org 10172 in Acute Stroke Treatment. Stroke 24:35–41
doi: 10.1161/01.STR.24.1.35
Brott T, Adams HP, Olinger CP, Marler JR, Barsan WG, Biller J et al (1989) Measurements of acute cerebral infarction: a clinical examination scale. Stroke 20:864–870
doi: 10.1161/01.STR.20.7.864
General Office of National Health Committee (2019) Notice on the issuance of a program for the diagnosis and treatment of novel coronavirus (2019-nCoV) infected pneumonia (trial revised fifth edition). http://www.nhc.gov.cn/yzygj/s7653p/202003/46c9294a7dfe4cef80dc7f5912eb1989.shtml . Accessed 18 Nov 2020
Loeffelholz MJ, Tang YM (2020) Laboratory diagnosis of emerging human coronavirus infections. The state of the art. Emerg Microbes Infect 9:747–756
doi: 10.1080/22221751.2020.1745095
Gareth J, Witten D, Hastie T, Tibshirani R (2013) An Introduction to Statistical Learning. Springer Texts in Statistics
Powers DMW (2011) Evaluation: from precision, recall and F-measure to ROC, informedness, markedness & correlation. J Mach Learn Technol 2:37–63
R Core Team (2019) R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. https://www.R-project.org/
Liaw A, Wiener M (2002) Classification and regression by randomForest. R News 2(3):18–22
Banerjee M, Ding Y, Noone AM (2012) Identifying representative trees from ensembles. Stat Med 31:1601–1616
doi: 10.1002/sim.4492
Slawski M, Daumer M, Boulesteix AL (2008) CMA—a comprehensive bioconductor package for supervised classification with high dimensional data. BMC Bioinform 9:1–17
doi: 10.1186/1471-2105-9-439
Cai H (2020) Sex difference and smoking predisposition in patients with COVID-19. Lancet Respir Med 8:e20
doi: 10.1016/S2213-2600(20)30117-X
Conti P, Younes A (2020) Coronavirus COV-19/SARS-CoV-2 affects women less than men: clinical response to viral infection. J Biol Regul Homeost Agents 34:339–343
pubmed: 32253888
Channappanavar R, Fett C, Mack M, Ten Eyck PP, Meyerholz DK, Perlman S (1950) Sex-based differences in susceptibility to Severe Acute Respiratory Syndrome Coronavirus infection. J Immunol Baltim Md 2017(198):4046–4053
Lubitz SA, Yin X, Rienstra M, Schnabel RB, Walkey AJ, Magnani JW et al (2015) Long-term outcomes of secondary atrial fibrillation in the community: the Framingham Heart Study. Circulation 131:1648–1655
doi: 10.1161/CIRCULATIONAHA.114.014058
Boos CJ, Anderson RA, Lip GY (2006) Is atrial fibrillation an inflammatory disorder? Eur Heart J 27:136–149
doi: 10.1093/eurheartj/ehi645
Engelmann MD, Svendsen JH (2005) Inflammation in the genesis and perpetuation of atrial fibrillation. Eur Heart J 26:2083–2092
doi: 10.1093/eurheartj/ehi350
Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J et al (2020) Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. JAMA 323:1061–1069
doi: 10.1001/jama.2020.1585
Bhatla A, Mayer MM, Adusumalli S, Hyman MC, Oh E, Tierney A et al (2020) COVID-19 and cardiac arrhythmias. Heart Rhythm 17:1439–1444
doi: 10.1016/j.hrthm.2020.06.016
Fowler RA, Lapinsky SE, Hallett D, Detsky AS, Sibbald WJ, Slutsky AS et al (2003) Toronto SARS Critical Care Group. Critically ill patients with severe acute respiratory syndrome. JAMA 290:367–373
doi: 10.1001/jama.290.3.367
Yu CM, Wong RSM, Wu EB, Kong SL, Wong J, Yip GWY et al (2006) Cardiovascular complications of severe acute respiratory syndrome. Postgrad Med J 82:140–144
doi: 10.1136/pgmj.2005.037515
Gupta N, Zhao YY, Evans CE (2019) The stimulation of thrombosis by hypoxia. Thromb Res 181:77–83
doi: 10.1016/j.thromres.2019.07.013
Connors JM, Levy JH (2020) COVID-19 and its implications for thrombosis and anticoagulation. Blood. https://doi.org/10.1182/blood.2020006000
doi: 10.1182/blood.2020006000 pubmed: 33211835 pmcid: 7440974
Saposnik G, Gladstone D, Raptis R, Zhou L, Hart RG (2013) Investigators of the Registry of the Canadian Stroke Network (RCSN) and the Stroke Outcomes Research Canada (SORCan) Working Group Atrial fibrillation in ischemic stroke: predicting response to thrombolysis and clinical outcomes. Stroke 44:99–104
doi: 10.1161/STROKEAHA.112.676551
Beyrouti R, Adams ME, Benjamin L, Cohen H, Farmer SF, Goh YY et al (2020) Characteristics of ischaemic stroke associated with COVID-19. J Neurol Neurosurg Psychiatry 91:889–891
doi: 10.1136/jnnp-2020-323586
Mouridsen K, Thurner P, Zaharchuk G (2020) Artificial intelligence applications in stroke. Stroke 51:2573–2579
doi: 10.1161/STROKEAHA.119.027479
Pezzini A, Grassi M, Del Zotto E, Giossi A, Volonghi I, Costa P et al (2013) Complications of acute stroke and the occurrence of early seizures. Cerebrovasc Dis 35:444–450
doi: 10.1159/000348704
Sacco S, Stracci F, Cerone D, Ricci S, Carolei A (2011) Epidemiology of stroke in Italy. Int J Stroke 6:219–227
doi: 10.1111/j.1747-4949.2011.00594.x

Auteurs

Alessandro Pezzini (A)

Department of Clinical and Experimental Sciences, University of Brescia, P.le Spedali Civili, 1, 25123, Brescia, Italy. ale_pezzini@hotmail.com.

Mario Grassi (M)

Department of Brain and Behavioural Sciences, Statistics and Genomic Unit, University of Pavia, Pavia, Italy.

Giorgio Silvestrelli (G)

Department of Neurology and Stroke Unit, Carlo Poma Hospital, ASST Mantova, Mantova, Italy.

Martina Locatelli (M)

Department of Clinical and Experimental Sciences, University of Brescia, P.le Spedali Civili, 1, 25123, Brescia, Italy.
Neurology Unit, Istituti Ospitalieri, ASST Cremona, Cremona, Italy.

Nicola Rifino (N)

Department of Neurology, Ospedale San Gerardo, ASST Monza, Monza, Italy.
Department of Medicine and Surgery and Milan Center for Neuroscience, University of Milano-Bicocca, Milan, Italy.

Simone Beretta (S)

Department of Neurology, Ospedale San Gerardo, ASST Monza, Monza, Italy.
Department of Medicine and Surgery and Milan Center for Neuroscience, University of Milano-Bicocca, Milan, Italy.

Massimo Gamba (M)

Vascular Neurology-Stroke Unit, Spedali Civili Hospital, ASST Spedali Civili, Brescia, Italy.

Elisa Raimondi (E)

Neurology Unit, Ospedale Nuovo, ASST Ovest Milanese, Legnano, Italy.

Giuditta Giussani (G)

Neurology Unit and Stroke Unit, Department of Neurosciences and Niguarda Neuro Center, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.

Federico Carimati (F)

Neurology Unit, Ospedale di Circolo e Fondazione Macchi, ASST Sette Laghi, Varese, Italy.

Davide Sangalli (D)

Neurology Unit, Ospedale "A. Manzoni", ASST Lecco, Lecco, Italy.

Manuel Corato (M)

Emergency Neurology and Stroke Unit, IRCCS Humanitas Clinical and Research Center, Rozzano, Milan, Italy.

Simonetta Gerevini (S)

Department of Neuroradiology, Papa Giovanni XXIII Hospital, ASST Papa Giovanni XXIII, Bergamo, Italy.

Stefano Masciocchi (S)

Department of Clinical and Experimental Sciences, University of Brescia, P.le Spedali Civili, 1, 25123, Brescia, Italy.

Matteo Cortinovis (M)

Department of Clinical and Experimental Sciences, University of Brescia, P.le Spedali Civili, 1, 25123, Brescia, Italy.

Sara La Gioia (S)

Department of Neurology, Papa Giovanni XXIII Hospital, ASST Papa Giovanni XXIII, Bergamo, Italy.

Francesca Barbieri (F)

Department of Neurology and Stroke Unit, Carlo Poma Hospital, ASST Mantova, Mantova, Italy.

Valentina Mazzoleni (V)

Department of Clinical and Experimental Sciences, University of Brescia, P.le Spedali Civili, 1, 25123, Brescia, Italy.

Debora Pezzini (D)

Department of Clinical and Experimental Sciences, University of Brescia, P.le Spedali Civili, 1, 25123, Brescia, Italy.

Sonia Bonacina (S)

Department of Clinical and Experimental Sciences, University of Brescia, P.le Spedali Civili, 1, 25123, Brescia, Italy.

Andrea Pilotto (A)

Department of Clinical and Experimental Sciences, University of Brescia, P.le Spedali Civili, 1, 25123, Brescia, Italy.

Alberto Benussi (A)

Department of Clinical and Experimental Sciences, University of Brescia, P.le Spedali Civili, 1, 25123, Brescia, Italy.

Mauro Magoni (M)

Vascular Neurology-Stroke Unit, Spedali Civili Hospital, ASST Spedali Civili, Brescia, Italy.

Enrico Premi (E)

Vascular Neurology-Stroke Unit, Spedali Civili Hospital, ASST Spedali Civili, Brescia, Italy.

Alessandro Cesare Prelle (AC)

Neurology Unit, Ospedale Nuovo, ASST Ovest Milanese, Legnano, Italy.

Elio Clemente Agostoni (EC)

Neurology Unit and Stroke Unit, Department of Neurosciences and Niguarda Neuro Center, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.

Fernando Palluzzi (F)

Department of Brain and Behavioural Sciences, Statistics and Genomic Unit, University of Pavia, Pavia, Italy.

Valeria De Giuli (V)

Neurology Unit, Istituti Ospitalieri, ASST Cremona, Cremona, Italy.

Anna Magherini (A)

Department of Neurology and Stroke Unit, Carlo Poma Hospital, ASST Mantova, Mantova, Italy.

Daria Valeria Roccatagliata (DV)

Department of Neurology and Stroke Unit, Carlo Poma Hospital, ASST Mantova, Mantova, Italy.

Luisa Vinciguerra (L)

Neurology Unit, Istituti Ospitalieri, ASST Cremona, Cremona, Italy.

Valentina Puglisi (V)

Neurology Unit, Istituti Ospitalieri, ASST Cremona, Cremona, Italy.

Laura Fusi (L)

Neurology Unit, Ospedale "Sant'Anna", ASST Lariana, Como, Italy.

Susanna Diamanti (S)

Department of Neurology, Ospedale San Gerardo, ASST Monza, Monza, Italy.
Department of Medicine and Surgery and Milan Center for Neuroscience, University of Milano-Bicocca, Milan, Italy.

Francesco Santangelo (F)

Department of Neurology, Ospedale San Gerardo, ASST Monza, Monza, Italy.
Department of Medicine and Surgery and Milan Center for Neuroscience, University of Milano-Bicocca, Milan, Italy.

Rubjona Xhani (R)

Neurology Unit, Ospedale "Sant'Anna", ASST Lariana, Como, Italy.

Federico Pozzi (F)

Neurology Unit, Ospedale "Sant'Anna", ASST Lariana, Como, Italy.

Giampiero Grampa (G)

Neurology Unit, Ospedale "Sant'Anna", ASST Lariana, Como, Italy.

Maurizio Versino (M)

Neurology Unit, Ospedale di Circolo e Fondazione Macchi, ASST Sette Laghi, Varese, Italy.

Andrea Salmaggi (A)

Neurology Unit, Ospedale "A. Manzoni", ASST Lecco, Lecco, Italy.

Simona Marcheselli (S)

Emergency Neurology and Stroke Unit, IRCCS Humanitas Clinical and Research Center, Rozzano, Milan, Italy.

Anna Cavallini (A)

Stroke Unit, IRCCS Fondazione "C. Mondino", Pavia, Italy.

Alessia Giossi (A)

Neurology Unit, Istituti Ospitalieri, ASST Cremona, Cremona, Italy.

Bruno Censori (B)

Neurology Unit, Istituti Ospitalieri, ASST Cremona, Cremona, Italy.

Carlo Ferrarese (C)

Department of Neurology, Ospedale San Gerardo, ASST Monza, Monza, Italy.
Department of Medicine and Surgery and Milan Center for Neuroscience, University of Milano-Bicocca, Milan, Italy.

Alfonso Ciccone (A)

Department of Neurology and Stroke Unit, Carlo Poma Hospital, ASST Mantova, Mantova, Italy.

Maria Sessa (M)

Department of Neurology, Papa Giovanni XXIII Hospital, ASST Papa Giovanni XXIII, Bergamo, Italy.

Alessandro Padovani (A)

Department of Clinical and Experimental Sciences, University of Brescia, P.le Spedali Civili, 1, 25123, Brescia, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH